Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 5654  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::  Article in PDF (223 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  References

 Article Access Statistics
    PDF Downloaded54    
    Comments [Add]    

Recommend this journal


Year : 2010  |  Volume : 56  |  Issue : 2  |  Page : 168

Glucoheptonate for diagnosis of brain tumor

Wiwanitkit House, Bangkhae, Bangkok - 10160, Thailand

Date of Web Publication8-Jul-2010

Correspondence Address:
V Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok - 10160
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0022-3859.65275

Rights and Permissions

How to cite this article:
Wiwanitkit V. Glucoheptonate for diagnosis of brain tumor. J Postgrad Med 2010;56:168

How to cite this URL:
Wiwanitkit V. Glucoheptonate for diagnosis of brain tumor. J Postgrad Med [serial online] 2010 [cited 2023 Mar 28];56:168. Available from:


I read the publication on glucoheptonate by Jaiswal et al., with great interest. Jaiswal et al. reached the conclusion that "Glucoheptonate has high degree of specificity for neoplastic tissues of brain and may be used as a tracer for SPECT study to differentiate neoplastic intracranial lesions from non-neoplastic ones." [1] Indeed, glucoheptonate is acceptable in brain oncological imaging. Recently, Barai et al., proposed that glucoheptonate contributed to a reliable diagnostic modality to differentiate tumor recurrence from post-radiation gliosis in patients with medulloblastoma. [2] Barai et al., also noted that glucoheptonate is helpful for diagnosis of recurrent brain tumor. [3] However, additional data on the clinical usefulness of glucoheptonate is still required. First, the cost of this advanced approach compared to its utility must be systematically assessed. Second, the ability of glucoheptonate to differentiate between primary and metastatic lesions and among different kinds and grades of malignancies is still to be proven.

 :: References Top

1.Jaiswal S, Barai S; Rajkumar, Gambhir S, Ora M, Mahapatra AK. Evaluation of intracranial space-occupying lesion with Tc99m-glucoheptonate brain single photon emission computed tomography in treatment-naοve patients. J Postgrad Med 2009;55:180-4.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Barai S, Bandopadhayaya GP, Julka PK, Kale SS, Kumar R, Malhotra A, et al. Evaluation of Tc99m-glucoheptonate for SPECT functional imaging of medulloblastoma. J Clin Neurosci 2005;12:36-8.  Back to cited text no. 2      
3.Barai S, Rajkamal, Bandopadhayaya GP, Pant GS, Haloi AK, Malhotra A, et al. Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. J Clin Neurosci 2005;12:27-31.  Back to cited text no. 3      


Print this article  Email this article
Previous article Next article
Online since 12th February '04
2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow